Product Information
AMLODIPINE-VALSARTAN 5-320 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3511 per EA under NDC 65862073830. Its NADAC has been published 517 times since Nov 9, 2016.
FDA first approved this application on Apr 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 320 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862073830
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206512FDA Approved
4/22/2016
TE Code
AB
On Market Since
4/22/2016
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-320 MG has been published 517 times since Nov 9, 2016, and over the history we have for it it has declined 47.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3511 per EA |
|---|---|
| All-time high | $0.6628 (Nov 16, 2016) |
| All-time low | $0.3511 (Sep 23, 2026) |
| 52-week high | $0.5476 |
| 52-week low | $0.3511 |
| Median price | $0.5605 |
| Average price | $0.5488 |
| Largest weekly change | +59.9% (Jun 19, 2024) |
| Weeks tracked | 517 |
| Tracking since | Nov 9, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and valsartan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-320 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-320 MG, manufactured by Aurobindo Pharma Limited, is $0.3511 per EA (NDC 65862073830), effective Sep 30, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-320 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has declined 47.0%. It has been tracked across 517 weekly CMS publications since Nov 9, 2016.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-320 MG?
Since Nov 9, 2016, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has ranged from a low of $0.3511 (Sep 23, 2026) to a high of $0.6628 (Nov 16, 2016), with a median of $0.5605 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-320 MG?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN 5-320 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN 5-320 MG?
AMLODIPINE-VALSARTAN 5-320 MG (NDC 65862073830) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.